2020-2022年紧急医疗服务激活中旁观者给予纳洛酮的趋势
这项回顾性横断面研究利用美国国家紧急医疗服务信息系统(NEMSIS)2020年6月至2022年6月的数据,纳入65 621 195次EMS激活(来自54个州和地区近14 000个机构),评估旁观者给予纳洛酮(LAN)的趋势。期间共744 078例患者接受纳洛酮,其中24 990例(3.4%)为LAN。EMS纳洛酮给药率下降6.1%(从每10万次EMS激活1140.1降至1070.1),而LAN率上升43.5%(从30.0升至43.1每10万次EMS激活)。作者认为这些发现有助于inform政策和实践,并指出需要新的公共卫生策略来评估该干预措施的效果、扩大纳洛酮分发和解决使用障碍。
要点
- 2020年6月至2022年6月,美国NEMSIS数据库中744 078例接受纳洛酮的患者里,24 990例(3.4%)为旁观者给予纳洛酮(LAN)。
- LAN率从每10万次EMS激活30.0(95%CI 29.2-30.8)升至43.1(95%CI 42.0-44.1),升幅43.5%。
- 同期EMS纳洛酮总给药率从每10万次EMS激活1140.1(95%CI 1135.1-1145.1)降至1070.1(95%CI 1064.9-1075.3),降幅6.1%。
- LAN接受者以男性为主(17 331例,69.4%),中位年龄42岁(IQR 31-56),86.8%(21 692例)在 urban 场所、52.9%(13 223例)在家庭或住所接受治疗。
- 全部纳洛酮接受者中,243 985例(32.8%)的主要或次要印象记录为疑似药物过量。
适用人群与场景
- 美国2020年6月至2022年6月EMS激活中接受纳洛酮的患者,激活类型包括911响应、EMS待命、救护车拦截或互助响应。
- 排除医疗场所内激活及院际或医疗转运。
研究设计与关键结果
- 研究类型:回顾性横断面研究,美国NEMSIS数据库,2020年6月至2022年6月。
- 样本:65 621 195次EMS激活(来自54个州和地区近14 000个机构);744 078例患者接受纳洛酮,其中24 990例(3.4%)为LAN。
- LAN接受者特征:男性17 331例(69.4%),中位年龄42岁(IQR 31-56);urban 21 692例(86.8%),家庭或住所13 223例(52.9%)。
- 全部纳洛酮接受者中243 985例(32.8%)有疑似药物过量记录(主要或次要印象)。
- 主要结局:EMS纳洛酮给药率从每10万次EMS激活1140.1(95%CI 1135.1-1145.1)降至1070.1(95%CI 1064.9-1075.3),变化-6.1%;LAN率从30.0(95%CI 29.2-30.8)升至43.1(95%CI 42.0-44.1),变化+43.5%。
证据类型、等级与局限
- 证据类型:回顾性横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现有助于inform旨在减轻阿片类药物流行破坏性影响和挽救生命的政策与实践。
- 作者认为需要新的公共卫生策略来在全国范围内测量该干预措施的效果、评估扩大纳洛酮分发的方法并解决纳洛酮使用障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Layperson-administered naloxone (LAN) is a powerful but incompletely characterized intervention to prevent opioid-related overdose mortality. LAN trends are relevant to policy and strategic planning in naloxone distribution initiatives.
OBJECTIVE: To assess the 2-year LAN trend for persons in the United States receiving naloxone during emergency medical services (EMS) activations.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study was conducted in the United States from June 2020 to June 2022 among 65 621 195 EMS activations from 911 responses, EMS standbys, or when EMS crews functioned in an ambulance intercept role or during mutual aid to another ambulance response. Activations within health care settings and interfacility or medical transports were excluded. Data are from the National Emergency Medical Services Information System (NEMSIS), the national EMS patient care record database. From June 2020 to June 2022, NEMSIS included more than 96 million EMS activations from nearly 14 000 agencies across 54 states and territories.
EXPOSURES: EMS clinician-reported LAN.
MAIN OUTCOME AND MEASURES: The primary outcome was the trend of receiving LAN, measured by EMS clinician documentation.
RESULTS: From June 2020 to June 2022, EMS reported 744 078 patients receiving naloxone, with 24 990 (3.4%) involving LAN. Patients were predominantly male (17 331 [69.4%]) and had a median (IQR) age of 42 (31-56) years, with the majority treated in urban homes or residences (21 692 [86.8%] urban; 13 223 [52.9%] in-home or residence). Of the total naloxone recipients, 243 985 patients (32.8%) had suspected drug overdose documentation as either the primary or secondary impression. Overall, the percentage change in naloxone administration rates decreased 6.1% over the study period (from 1140.1 [95% CI, 1135.1-1145.1] per 100 000 EMS activations to 1070.1 [95% CI, 1064.9-1075.3] per 100 000 EMS activations), while the percentage change of persons receiving LAN increased 43.5% (from 30.0 [95% CI, 29.2-30.8] per 100 000 EMS activations to 43.1 [95% CI, 42.0-44.1] per 100 000 EMS activations).
CONCLUSIONS AND RELEVANCE: In this cross-sectional study, the LAN rate increased from June 2020 to June 2022 as reported in the national EMS database. These findings help inform policies and practices aimed at mitigating the devastating impacts of the opioid epidemic and saving lives. Novel public health strategies are needed to measure the effects of this intervention nationally, evaluate approaches to expand naloxone distribution, and address naloxone usage barriers.
参考来源
- Gage CB, Powell JR, Ulintz A, et al. Layperson-Administered Naloxone Trends Reported in Emergency Medical Service Activations, 2020-2022. JAMA Netw Open. 2024. PMID: 39401035. doi:10.1001/jamanetworkopen.2024.39427
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。